Latest filing published 19 Aug 2021 for Oasmia Pharmaceutical AB, €5,166.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Härfstrand: trading record in brief
All filings by Anders Härfstrand on record concern Oasmia Pharmaceutical AB. We count 3 filings; the first trade dates from 12 October 2020 and the latest from 19 August 2021.
On the market, this insider has only ever bought: 3 purchases, €46k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2021, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €13k.
On 19 August 2021 came the latest disclosure, an open-market purchase for €5,166 in Oasmia Pharmaceutical AB. Most trades are made public on the day they happen. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Anders Härfstrand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ SEK 2.6566AktieISIN SE0000722365FI:csv-e9b7afde36635b896086Canonical exit: 17 Nov 2021 (T+90)
- 100,000 shares@ SEK 2.8565AktieISIN SE0000722365FI:csv-cd1ea5408edaa59e96a1Canonical exit: 4 Oct 2021 (T+90)
- 30,000 shares@ SEK 4.36100.0% of flowAktieISIN SE0000722365FI:csv-04398a8a5ec6bb3718a1Canonical exit: 10 Jan 2021 (T+90)
3 of 3 declarations